PNLIP and familial hypercholesterolemia: Notably, inhibiting the activity of triglyceride-hydrolyzing enzymes, such as cholesterol esterase and pancreatic lipase, has emerged as a viable strategy for managing hypercholesterolemia and mitigating its associated complications [28].